Page last updated: 2024-11-01

cm 7116 and Drug Withdrawal Symptoms

cm 7116 has been researched along with Drug Withdrawal Symptoms in 1 studies

norflutoprazepam: structure

Research Excerpts

ExcerptRelevanceReference
"To assess pharmacodynamic and pharmacokinetic properties of acute, subchronic and withdrawn quazepam, a single-blind, longitudinal study was run in eight male, healthy young volunteers."1.28Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam. ( Kauert, G; Klausnitzer, W; Schaffler, K; Wauschkuhn, CH, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schaffler, K1
Kauert, G1
Wauschkuhn, CH1
Klausnitzer, W1

Other Studies

1 other study available for cm 7116 and Drug Withdrawal Symptoms

ArticleYear
Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Electrooculography; Flurazepam; Hemo

1989